Vladimir F. Semiglazov, Vladislav V. Semiglazov, Garik A. Dashyan, Elena K. Ziltsova, Vadim G. Ivanov, Alla A. Bozhok, Olga A. Melnikova, Ruslan M. Paltuev, Alexander Kletzel and Lev M. Berstein Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer Cancer 110
Article first published online: 30 MAY 2007 | DOI: 10.1002/cncr.22789
This phase 2 randomized controlled trial evaluated the efficacy of neoadjuvant treatment with aromatase inhibitors compared with neoadjuvant chemotherapy in postmenopausal women with hormone receptor-positive breast cancer. Aromatase inhibitors were well tolerated, and rates of overall objective response and breast-conserving surgery were similar in both treatment groups.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field